Industry Verticals »

All Categories

Insights »

About TMR »

Hemostasis and Tissue Sealing Agents Market

Schedule a Call

Hemostasis and Tissue Sealing Agents Market

Hemostasis and Tissue Sealing Agents Market (Topical Hemostats - Mechanical Hemostats, Active Hemostats & Flowable Hemostats and Adhesive and Tissue Sealing Agents - Natural Tissue Sealants, Synthetic Tissue Sealants & Adhesion Barrier Products) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global hemostasis and tissue sealing agents market for the historical period 2017–2018 and forecast period 2019–2027, a rise in demand for minimally invasive procedures and an increase in the global geriatric population are projected to drive the global market for hemostasis and tissue sealing agents during the forecast period
  • According to the report, the global hemostasis & tissue sealing agents market was valued at US$ 5.1 Bn in 2018 and is anticipated to expand at a CAGR of 8.3% from 2019 to 2027

Request a sample to get extensive insights into the Automotive Heat Shield Market

Rise in demand for minimally invasive procedures: Key Drivers

  • The preference for minimally invasive surgeries has increased significantly in the past few years. Minimally invasive surgeries have advantages such as shorter hospital stay, minimal incision, fewer post-surgical complications, and shorter recovery time. Systemic hemostatic agents such as gelatin and collagen-based hemostat powders are widely used in minimally invasive procedures. These agents enable surgeons to perform complex surgeries.
  • According to a study conducted by the World Health Organization (WHO), approximately 234.2 million major surgical procedures are undertaken by various hospitals and surgical centers across the world each year. Thus, the rising number of surgical procedures and growing preference for minimally invasive procedures boost the demand for the Hemostasis and tissue sealing agents market.

To understand how our report can bring a difference to your business strategy, Ask for a brochure

The aging population increases the number of surgeries needing hemostat products boosting the market growth

  • Treatment services have become affordable due to improvements in healthcare policies in countries such as the U.S., Japan, the U.K., and China. This, in turn, has increased the life expectancy of the population. Consequently, the rise in the geriatric population increases the number of surgical procedures that use adhesion barriers and hemostat products. According to the U.S. Department of Health & Human Product estimates, the U.S. will have about 72.1 Mn geriatric population by 2030, which is more than twice the number in 2000.
  • The UN Population Division has projected that the number of people aged 60 years and above will increase significantly during 2015–2030. In developed countries, the total proportion of people aged 60 years and above has increased from 12% in 1950 to 22% in 2011 and is expected to reach 32% by 2050. Thus, the aging population drives the uptake of hemostats, tissue sealants, and adhesion barrier products and boosts market growth.

High cost and strict regulatory requirements to Hamper Market

  • Hemostat and tissue sealant product development is a complex and expensive process. Regulatory approval of hemostat products demands valid scientific evidence, well-controlled investigations, and documented case studies. Despite the high expense incurred for the development of hemostat products by manufacturers, the success rate of the approval of these products by regulatory bodies is low. The low efficacy and safety of the products have been attributed to the low approval rate of hemostat products. Only a small number of companies have entered the market due to setbacks faced in clinical studies by hemostat manufacturers. This hampers the growth of the hemostasis and tissue sealing agents market.

Global Hemostasis and tissue sealing agents Market: Competitive Landscape

  • This report profiles major players in the global hemostasis and tissue sealing agents industry based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global Hemostasis and tissue sealing agents market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global Hemostasis and tissue sealing agents business are
    • Advanced Medical Solutions Group plc
    • Baxter
    • Cohera Medical, Inc.
    • CryoLife, Inc.
    • C.R. Bard, Inc.
    • Johnson & Johnson Services, Inc.
    • Integra LifeSciences Corporation
    • Pfizer, Inc.
    • Cohesion Technologies Inc.
    • B Braun Medical Inc
    • other prominent players.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Hemostasis and Tissue Sealing Agents Market

Global Hemostasis and Tissue Sealing Agents Industry: Key Developments

Key players in the global hemostasis and tissue sealing agents market are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global market. A few expansion strategies adopted by players operating in the global market for Hemostasis and tissue sealing agents are:

  • In July 2020, Sysmex Corporation launched a new product in the hemostasis field i.e. Automated Blood Coagulation Analyzers, which is used for chemiluminescence enzyme immunoassay to enhance testing workflow efficiency
  • On January 26, 2020, Terumo Corporation launched a new surgical sealant product i.e. AQUABRID in EMEA Market. This product helps to stop bleeding during aortic surgical procedures.
  • In January 2018, Baxter acquired two hemostat and sealant products i.e. RECOTHROM and PREVELEAK from Mallinckrodt plc for broadening the portfolio of innovative surgical products.

The report on the global market for hemostasis and tissue sealing agents discussed individual strategies, followed by company profiles of manufacturers of hemostasis and tissue sealing agents. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global hemostasis and tissue sealing agents market.

Global Hemostasis and Tissue Sealing Agents Market – Segmentation

Type
  • Topical Hemostat
    • Mechanical Hemostats
    • Active Hemostats
    • Flowable Hemostats
  • Adhesive and Tissue Sealing Agents
    • Natural Tissue Sealant
    • Synthetic Tissue Sealant
    • Adhesion Barrier Products

Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of hemostasis and tissue sealing agents market?

The global market for Hemostasis and tissue sealing agents to reach the valuation of US$ 10.3 Bn by 2027

What is the anticipated CAGR of the hemostasis & tissue sealing agents market in the forecast period?

The global market is anticipated to expand at a CAGR of 8.3% from 2019 to 2027

What are the key driving factors for the growth of the global market for hemostasis and tissue sealing agents?

Hemostasis & tissue sealing agents market is driven by a rise in demand for minimally invasive procedures and an increase in the global geriatric population

Which region is expected to project the highest market share in the global hemostasis and tissue sealing agents business?

North America held the largest share of the global market for hemostasis and tissue-sealing agents

Who are the key players in the global hemostasis and tissue sealing agents business?

Key players in the hemostasis and tissue sealing agents market include Advanced Medical Solutions Group PLC, Cohera Medical, Inc., C. R. Bard, Inc., Integra Life Sciences Corporation, Cohesion Technologies Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Hemostasis and Tissue Sealing Agents Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key Development in the Market

        5.2. Mergers & Acquisitions

        5.3. COVID-19 Impact Analysis

    6. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Type, 2017–2027

            6.2.1. Topical Hemostat

                6.2.1.1. Mechanical Hemostats

                    6.2.1.1.1. Collagen based Topical Hemostats

                    6.2.1.1.2. ORC based Topical Hemostats

                    6.2.1.1.3. Gelatin based Topical Hemostats

                    6.2.1.1.4. Polysaccharide based Topical Hemostats

                6.2.1.2. Active Hemostats

                6.2.1.3. Flowable Hemostats

            6.2.2.  Adhesive and Tissue Sealing Agents

                6.2.2.1. Natural Tissue Sealant

                6.2.2.2. Synthetic Tissue Sealant

                6.2.2.3. Adhesion Barrier Products

        6.3. Global Hemostasis and Tissue Sealing Agents Market Analysis, by Type

        6.4. Global Hemostasis and Tissue Sealing Agents Market Attractiveness, by Type

    7. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Region

        7.1. Key Findings

        7.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Region

            7.2.1. North America

            7.2.2. Europe

            7.2.3. Asia Pacific

            7.2.4. Latin America

            7.2.5. Middle East & Africa

        7.3. North America Hemostasis and Tissue Sealing Agents Market Attractiveness, by Region

    8. North America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

        8.1. Introduction

            8.1.1. Key Findings

        8.2. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

            8.2.1. Topical Hemostat

                8.2.1.1. Mechanical Hemostats

                    8.2.1.1.1. Collagen based Topical Hemostats

                    8.2.1.1.2. ORC based Topical Hemostats

                    8.2.1.1.3. Gelatin based Topical Hemostats

                    8.2.1.1.4. Polysaccharide based Topical Hemostats

                8.2.1.2. Active Hemostats

                8.2.1.3. Flowable Hemostats

            8.2.2.  Adhesive and Tissue Sealing Agents

                8.2.2.1. Natural Tissue Sealant

                8.2.2.2. Synthetic Tissue Sealant

                8.2.2.3. Adhesion Barrier Products

        8.3. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country, 2017–2027

            8.3.1. U.S.

            8.3.2. Canada

        8.4. North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

            8.4.1. By Type

            8.4.2. By Country

    9. Europe Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

            9.2.1. Topical Hemostat

                9.2.1.1. Mechanical Hemostats

                    9.2.1.1.1. Collagen based Topical Hemostats

                    9.2.1.1.2. ORC based Topical Hemostats

                    9.2.1.1.3. Gelatin based Topical Hemostats

                    9.2.1.1.4. Polysaccharide based Topical Hemostats

                9.2.1.2. Active Hemostats

                9.2.1.3. Flowable Hemostats

            9.2.2.  Adhesive and Tissue Sealing Agents

                9.2.2.1. Natural Tissue Sealant

                9.2.2.2. Synthetic Tissue Sealant

                9.2.2.3. Adhesion Barrier Products

        9.3. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            9.3.1. Germany

            9.3.2. U.K.

            9.3.3. France

            9.3.4. Spain

            9.3.5. Italy

            9.3.6. Rest of Europe

        9.4. Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

            9.4.1. By Type

            9.4.2. By Country/Sub-region

    10. Asia Pacific Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

            10.2.1. Topical Hemostat

                10.2.1.1. Mechanical Hemostats

                    10.2.1.1.1. Collagen based Topical Hemostats

                    10.2.1.1.2. ORC based Topical Hemostats

                    10.2.1.1.3. Gelatin based Topical Hemostats

                    10.2.1.1.4. Polysaccharide based Topical Hemostats

                10.2.1.2. Active Hemostats

                10.2.1.3. Flowable Hemostats

            10.2.2.  Adhesive and Tissue Sealing Agents

                10.2.2.1. Natural Tissue Sealant

                10.2.2.2. Synthetic Tissue Sealant

                10.2.2.3. Adhesion Barrier Products

        10.3. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            10.3.1. China

            10.3.2. Japan

            10.3.3. India

            10.3.4. Australia & New Zealand

            10.3.5. Rest of Asia Pacific

        10.4. Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

            10.4.1. By Type

            10.4.2. By Country/Sub-region

    11. Latin America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

            11.2.1. Topical Hemostat

                11.2.1.1. Mechanical Hemostats

                    11.2.1.1.1. Collagen based Topical Hemostats

                    11.2.1.1.2. ORC based Topical Hemostats

                    11.2.1.1.3. Gelatin based Topical Hemostats

                    11.2.1.1.4. Polysaccharide based Topical Hemostats

                11.2.1.2. Active Hemostats

                11.2.1.3. Flowable Hemostats

            11.2.2.  Adhesive and Tissue Sealing Agents

                11.2.2.1. Natural Tissue Sealant

                11.2.2.2. Synthetic Tissue Sealant

                11.2.2.3. Adhesion Barrier Products

        11.3. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.3.1. Brazil

            11.3.2. Mexico

            11.3.3. Rest of Latin America Latin America

        11.4. Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

            11.4.1. By Type

            11.4.2. By Country/Sub-region

    12. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027

            12.2.1. Topical Hemostat

                12.2.1.1. Mechanical Hemostats

                    12.2.1.1.1. Collagen based Topical Hemostats

                    12.2.1.1.2. ORC based Topical Hemostats

                    12.2.1.1.3. Gelatin based Topical Hemostats

                    12.2.1.1.4. Polysaccharide based Topical Hemostats

                12.2.1.2. Active Hemostats

                12.2.1.3. Flowable Hemostats

            12.2.2.  Adhesive and Tissue Sealing Agents

                12.2.2.1. Natural Tissue Sealant

                12.2.2.2. Synthetic Tissue Sealant

                12.2.2.3. Adhesion Barrier Products

        12.3. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.3.1. GCC Countries

            12.3.2. South Africa

            12.3.3. Rest of Middle East & Africa

        12.4. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis

            12.4.1. By Application

            12.4.2. By Country/Sub-region

    13. Competition Landscape

        13.1. Market Player - Competition Matrix (by Tier and Size of companies)

        13.2. Market Share / Position Analysis, by Company, 2019

        13.3. Company Profiles

            13.3.1. Advanced Medical Solutions Group plc  

                13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.3.1.2. Financial Analysis

                13.3.1.3. Growth Strategies

                13.3.1.4. SWOT Analysis

            13.3.2. Baxter

                13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.3.2.2. Financial Analysis

                13.3.2.3. Growth Strategies

                13.3.2.4. SWOT Analysis

            13.3.3. Cohera Medical, Inc .

                13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.3.3.2. Financial Analysis

                13.3.3.3. Growth Strategies

                13.3.3.4. SWOT Analysis

            13.3.4. CryoLife, Inc .

                13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.3.4.2. Financial Analysis

                13.3.4.3. Growth Strategies

                13.3.4.4. SWOT Analysis

            13.3.5. C.R. Bard, Inc  

                13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.3.5.2. Financial Analysis

                13.3.5.3. Growth Strategies

                13.3.5.4. SWOT Analysis

            13.3.6. Johnson & Johnson Services, Inc  

                13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.3.6.2. Financial Analysis

                13.3.6.3. Growth Strategies

                13.3.6.4. SWOT Analysis

            13.3.7. Integra LifeSciences Corporation.

                13.3.7.1.  Company Overview (HQ, Business Segments, Employee Strength)

                13.3.7.2. Financial Analysis

                13.3.7.3. Growth Strategies

                13.3.7.4. SWOT Analysis

            13.3.8. Pfizer, Inc.  

                13.3.8.1.  Company Overview (HQ, Business Segments, Employee Strength)

                13.3.8.2. Financial Analysis

                13.3.8.3. Growth Strategies

                13.3.8.4. SWOT Analysis

            13.3.9. Cohesion Technologies Inc.  

                13.3.9.1.  Company Overview (HQ, Business Segments, Employee Strength)

                13.3.9.2. Financial Analysis

                13.3.9.3. Growth Strategies

                13.3.9.4. SWOT Analysis

            13.3.10. B Braun Medical Inc.  

                13.3.10.1.  Company Overview (HQ, Business Segments, Employee Strength)

                13.3.10.2. Financial Analysis

                13.3.10.3. Growth Strategies

                13.3.10.4. SWOT Analysis

            13.3.11. Other prominent Players

    List of Table

    Table 01: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017–2027

    Table 02: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

    Table 03: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

    Table 04: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

    Table 05: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Region, 2017–2027

    Table 06: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

    Table 07: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

    Table 08: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

    Table 09: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

    Table 10: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country, 2017-2027

    Table 11: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

    Table 12: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

    Table 13: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

    Table 14: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

    Table 15: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 16: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

    Table 17: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

    Table 18: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

    Table 19: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

    Table 20: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 21: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

    Table 22: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

    Table 23: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

    Table 24: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

    Table 25: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    Table 26: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027

    Table 27: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027

    Table 28: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027

    Table 29: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027

    Table 30: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

    List of Figure

    Figure 01: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, 2019–2027

    Figure 02: Market Value Share, by Type (2018)

    Figure 04: Market Value Share, by Region (2018)

    Figure 05: Global Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

    Figure 06: Global Hemostasis and Tissue Sealing Agents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Hemostat, 2017–2027

    Figure 07: Global Hemostasis and Tissue Sealing Agents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Adhesive and Tissue Sealing Agents, 2017–2027

    Figure 08: Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027

    Figure 09: Global Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Region, 2018 and 2027

    Figure 10: Global Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Region 2019-2027

    Figure 11: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, 2017–2027

    Figure 12: North America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

    Figure 13: North America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country, 2018 and 2027

    Figure 14: North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019–2027

    Figure 15: North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country, 2019-2027

    Figure 16: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 17: Europe Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

    Figure 18: Europe Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 19: Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027

    Figure 20: Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

    Figure 21: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 22: Asia Pacific Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

    Figure 23: Asia Pacific Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 24: Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027

    Figure 25: Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

    Figure 26: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, 2017–2027

    Figure 27: Latin America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

    Figure 28: Latin America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country, 2018 and 2027

    Figure 29: Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019–2027

    Figure 30: Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country, 2019-2027

    Figure 31: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 32: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027

    Figure 33: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 34: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027

    Figure 35: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

    Figure 36: Global Hemostasis and Tissue Sealing Agents Market Share Analysis, by Company (2019)

Copyright © Transparency Market Research, Inc. All Rights reserved